Plasma Substitute


Also found in: Dictionary, Thesaurus, Medical.

Plasma Substitute

 

a fluid that exerts the same mechanical and oncotic effects as whole blood or plasma but—unlike plasma—does not have clotting capacity or the ability to undergo an immune response.

References in periodicals archive ?
Synthetic colloidal plasma substitutes can be divided into products based on dextran, starch, or gelatin (4).
Helicon chairman Dr Saliba Sassine said: ``We believe that Volplex is a very good product that will be positioned as a high quality blood plasma substitute.
Dr Saliba Sassine, chairman of Helicon, said, 'We believe that Volplex is a very good product that will be positioned as a high-quality blood plasma substitute.
SPECIALIST health care products company Maelor, which is headquartered in Wrexham, has appointed an exclusive distributor in Bangladesh for its blood plasma substitute Volplex.
SHARES in healthcare company Maelor jumped 12pc yesterday as the group launched a blood plasma substitute to treat patients with severe blood loss.
Over the past year the company has refocused and is now concentrating on its catheter maintenance system OptiFlo, blood plasma substitute Volplex, anaesthetic lubricant TendaGel, micelle propofol anaesthetic and a micelle drug delivery platform.
Maelor's blood plasma substitute Volplex will now be sold, marketed and distributed in Sub-Saharan Africa by Adcock Ingram.
SPECIALIST healthcare products company Maelor has taken another step towards securing a place in the Australian market for its blood plasma substitute Volplex.
Orders for the company's OptiFlo catheter management system were expected to be much higher in the second half of the financial year and the business would also benefit from revenues from its blood plasma substitute Volplex, which was launched in the UK this week.
NORTH Wales-based specialist healthcare products company Maelor is this week launching its blood plasma substitute Volplex in the UK.
Company chairman Alastair Macpherson told shareholders at the AGM that the company had also recently won approval for its blood plasma substitute, Volplex.
The company has so far enjoyed revenue streams from OptiFlo which has secured a 26pc share of the highly competitive UK market and from a blood plasma substitute intermediate product which is sold in the Middle East.

Full browser ?